Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × OTHER × erdafitinib × Clear all

Phase

Phase 2 5 Phase NA 1 Phase EARLY_PHASE1 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 1

Interventions

Exercise 335 Blood Specimen Collection 271 Standard of Care 241 Magnetic Resonance Spectroscopy 205 Surveys and Questionnaires 200 Radiosurgery 200 Educational Status 189 Radiotherapy 186 Methods 185 Early Intervention, Educational 158 Practice Guidelines as Topic 118 Interviews as Topic 114 Drug Therapy 104 Acupuncture Therapy 104 Control Groups 102 Biopsy 101 Surgical Procedures, Operative 100 Palliative Care 82 Therapeutics 78 Resistance Training 73 Counseling 73 Magnetic Resonance Imaging 72 Cyclophosphamide 72 Saline Solution 70 Cognitive Behavioral Therapy 64 Radiotherapy, Intensity-Modulated 60 Specimen Handling 59 Radiofrequency Ablation 59 Cisplatin 58 Yoga 56

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06328491 2024-03-25

Erdafitinib in Metastatic Steroid-cell Ovarian Cancer

University Health Network, Toronto

Phase NA Completed

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡